Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

173 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Genome-wide association study of antipsychotic-induced QTc interval prolongation.
Aberg K, Adkins DE, Liu Y, McClay JL, Bukszár J, Jia P, Zhao Z, Perkins D, Stroup TS, Lieberman JA, Sullivan PF, van den Oord EJ. Aberg K, et al. Pharmacogenomics J. 2012 Apr;12(2):165-72. doi: 10.1038/tpj.2010.76. Epub 2010 Oct 5. Pharmacogenomics J. 2012. PMID: 20921969 Free PMC article.
Genome-wide pharmacogenomic analysis of response to treatment with antipsychotics.
McClay JL, Adkins DE, Aberg K, Stroup S, Perkins DO, Vladimirov VI, Lieberman JA, Sullivan PF, van den Oord EJ. McClay JL, et al. Among authors: aberg k. Mol Psychiatry. 2011 Jan;16(1):76-85. doi: 10.1038/mp.2009.89. Epub 2009 Sep 1. Mol Psychiatry. 2011. PMID: 19721433 Free PMC article. Clinical Trial.
Genomewide association study of movement-related adverse antipsychotic effects.
Aberg K, Adkins DE, Bukszár J, Webb BT, Caroff SN, Miller DD, Sebat J, Stroup S, Fanous AH, Vladimirov VI, McClay JL, Lieberman JA, Sullivan PF, van den Oord EJ. Aberg K, et al. Biol Psychiatry. 2010 Feb 1;67(3):279-82. doi: 10.1016/j.biopsych.2009.08.036. Epub 2009 Oct 28. Biol Psychiatry. 2010. PMID: 19875103 Free PMC article.
Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs.
Adkins DE, Aberg K, McClay JL, Bukszár J, Zhao Z, Jia P, Stroup TS, Perkins D, McEvoy JP, Lieberman JA, Sullivan PF, van den Oord EJ. Adkins DE, et al. Among authors: aberg k. Mol Psychiatry. 2011 Mar;16(3):321-32. doi: 10.1038/mp.2010.14. Epub 2010 Mar 2. Mol Psychiatry. 2011. PMID: 20195266 Free PMC article. Clinical Trial.
Genome-wide pharmacogenomic study of neurocognition as an indicator of antipsychotic treatment response in schizophrenia.
McClay JL, Adkins DE, Aberg K, Bukszár J, Khachane AN, Keefe RS, Perkins DO, McEvoy JP, Stroup TS, Vann RE, Beardsley PM, Lieberman JA, Sullivan PF, van den Oord EJ. McClay JL, et al. Among authors: aberg k. Neuropsychopharmacology. 2011 Feb;36(3):616-26. doi: 10.1038/npp.2010.193. Epub 2010 Nov 24. Neuropsychopharmacology. 2011. PMID: 21107309 Free PMC article.
SNP-based analysis of neuroactive ligand-receptor interaction pathways implicates PGE2 as a novel mediator of antipsychotic treatment response: data from the CATIE study.
Adkins DE, Khachane AN, McClay JL, Aberg K, Bukszár J, Sullivan PF, van den Oord EJ. Adkins DE, et al. Among authors: aberg k. Schizophr Res. 2012 Mar;135(1-3):200-1. doi: 10.1016/j.schres.2011.11.002. Epub 2011 Nov 17. Schizophr Res. 2012. PMID: 22099390 Free PMC article. No abstract available.
173 results